Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03616483 · ClinicalTrials.gov registry record
The Indiana Myeloma Registry
A clinical trial of Plasma Cell Dyscrasias, sponsored by Indiana University.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 1
- Study location
NCT03616483: Recruiting study of Plasma Cell Dyscrasias, sponsored by Indiana University.
NCT03616483 is a study of Plasma Cell Dyscrasias that is actively recruiting participants, run by Indiana University. The registered enrollment target is 2,500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03616483, a study of Plasma Cell Dyscrasias, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
Primary Outcome
The primary objective of this study is to provide a mechanism to store comprehensive clinical, genomic, demographic, social, environmental and quality of life data from subjects with plasma cell dyscrasias
Conditions Studied
Interventions
- OTHER This is a non-interventional trial
Study Locations (1)
Indiana
- Indiana University Simon Cancer Center - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2028-06-30 |
What NCT03616483 shows while recruiting
NCT03616483 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Plasma Cell Dyscrasias appearing as the primary indexed condition, and to 1 intervention - of which This is a non-interventional trial is the first listed.
NCT03616483 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT03616483 about?
NCT03616483 is a clinical study titled "The Indiana Myeloma Registry". This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
What is the current status of trial NCT03616483?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2018-06-18. Estimated completion is 2028-06-30.
What conditions does trial NCT03616483 study?
This clinical trial studies the following conditions: Plasma Cell Dyscrasias.
What interventions are being tested in trial NCT03616483?
The interventions under investigation include: This is a non-interventional trial (OTHER).
Who is sponsoring clinical trial NCT03616483?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03616483 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plasma Cell Dyscrasias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI